03:24:45 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-02-27 Bokslutskommuniké 2024
2024-11-28 Kvartalsrapport 2024-Q3
2024-08-27 Kvartalsrapport 2024-Q2
2024-06-20 Ordinarie utdelning AXIC A 0.00 SEK
2024-06-19 Årsstämma 2024
2024-05-23 Kvartalsrapport 2024-Q1
2024-03-06 Extra Bolagsstämma 2024
2024-03-05 Bokslutskommuniké 2023
2023-11-22 Kvartalsrapport 2023-Q3
2023-08-23 Kvartalsrapport 2023-Q2
2023-06-19 Ordinarie utdelning AXIC A 0.00 SEK
2023-06-16 Årsstämma 2023
2023-05-24 Kvartalsrapport 2023-Q1
2023-02-23 Bokslutskommuniké 2022
2022-11-24 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-06-01 Ordinarie utdelning AXIC A 0.00 SEK
2022-05-31 Årsstämma 2022
2022-05-24 Kvartalsrapport 2022-Q1
2022-02-17 Bokslutskommuniké 2021
2021-11-11 Kvartalsrapport 2021-Q3
2021-08-31 Kvartalsrapport 2021-Q2
2021-05-31 Ordinarie utdelning AXIC A 0.00 SEK
2021-05-28 Årsstämma 2021
2021-05-20 Kvartalsrapport 2021-Q1
2021-02-24 Bokslutskommuniké 2020
2020-11-12 Kvartalsrapport 2020-Q3
2020-08-21 Kvartalsrapport 2020-Q2
2020-05-27 Ordinarie utdelning AXIC A 0.00 SEK
2020-05-26 Årsstämma 2020
2020-05-14 Kvartalsrapport 2020-Q1
2020-02-27 Bokslutskommuniké 2019
2019-11-14 Kvartalsrapport 2019-Q3
2019-08-29 Kvartalsrapport 2019-Q2
2019-05-29 Ordinarie utdelning AXIC A 0.00 SEK
2019-05-28 Årsstämma 2019
2019-05-23 Kvartalsrapport 2019-Q1
2019-02-27 Bokslutskommuniké 2018
2018-11-15 Kvartalsrapport 2018-Q3
2018-08-29 Kvartalsrapport 2018-Q2
2018-06-01 Ordinarie utdelning AXIC A 0.00 SEK
2018-05-31 Årsstämma 2018
2018-05-15 Kvartalsrapport 2018-Q1
2018-02-27 Bokslutskommuniké 2017
2017-11-23 Kvartalsrapport 2017-Q3
2017-08-24 Kvartalsrapport 2017-Q2
2017-06-01 Ordinarie utdelning AXIC A 0.00 SEK
2017-05-31 Årsstämma 2017
2017-05-31 Kvartalsrapport 2017-Q1
2017-05-24 Kvartalsrapport 2017-Q1
2017-02-23 Bokslutskommuniké 2016
2016-11-24 Kvartalsrapport 2016-Q3
2016-08-25 Kvartalsrapport 2016-Q2
2016-05-24 Ordinarie utdelning AXIC A 0.00 SEK
2016-05-23 Årsstämma 2016
2016-05-19 Kvartalsrapport 2016-Q1
2016-02-25 Bokslutskommuniké 2015
2015-11-25 Kvartalsrapport 2015-Q3
2015-08-26 Kvartalsrapport 2015-Q2
2015-05-29 Ordinarie utdelning AXIC A 0.00 SEK
2015-05-28 Årsstämma 2015
2015-05-25 Kvartalsrapport 2015-Q1
2015-02-26 Bokslutskommuniké 2014
2014-11-24 Kvartalsrapport 2014-Q3
2014-08-28 Kvartalsrapport 2014-Q2
2014-05-22 Årsstämma 2014
2014-05-22 Kvartalsrapport 2014-Q1
2014-02-28 Bokslutskommuniké 2013
2013-11-29 Kvartalsrapport 2013-Q3
2013-08-26 Kvartalsrapport 2013-Q2
2013-06-28 Split AXIC A 4:1
2013-05-30 Kvartalsrapport 2013-Q1
2013-05-21 Ordinarie utdelning AXIC A 0.00 SEK
2013-05-20 Årsstämma 2013
2013-02-28 Bokslutskommuniké 2012
2012-11-26 Kvartalsrapport 2012-Q3
2012-08-30 Kvartalsrapport 2012-Q2
2012-05-28 Kvartalsrapport 2012-Q1
2012-05-17 Ordinarie utdelning AXIC A 0.00 SEK
2012-05-16 Årsstämma 2012
2012-02-29 Bokslutskommuniké 2011
2011-11-28 Kvartalsrapport 2011-Q3
2011-08-30 Kvartalsrapport 2011-Q2
2011-05-30 Kvartalsrapport 2011-Q1
2011-05-10 Ordinarie utdelning AXIC A 0.00 SEK
2011-05-09 Årsstämma 2011
2011-02-25 Bokslutskommuniké 2010
2010-05-11 Ordinarie utdelning AXIC A 0.00 SEK

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorMaterial
IndustriPlast, kemikalier & fetter
aXichem är verksamt inom industriell bioteknik. Bolaget utvecklar, patenterar och marknadsför industrikemikalier. Bolaget arbetar framförallt med Fenylcapsaicin, en naturanalog syntetisk capsaicin med tillämpningar inom en mängd olika områden, såsom inom den marina sektorn, bland skadedjursbekämpning i skogs-och jordbruk, samt bland enskilda farmaceutiska arbetsområden. Verksamhet drivs på global nivå, med huvudkontoret i Malmö.
2023-01-25 08:30:00

aXichem AB (https://www.axichem.com/) (publ), a developer of natural analogue industrial compounds, announces that Chr. Olesen (https://www.chr-olesen.dk/) a leading distributor of feed ingredients in Europe and the Americas, has added aXichem's proprietary ingredient aXiphen[®] to their official product portfolio. The inclusion of aXiphen in the product line is the first step in a pre-launch marketing program and further confirms Chr. Olesen's commitment to providing innovative and high-quality feed solutions to the market.

"We are looking forward to the coming feed additive approval in Europe and the product registration in South America for aXiphen, and to fully market and sell this innovative ingredient to leading feed producers," says Christian D. Olesen, Head of Business Development Feed at Chr. Olesen. "I'm thrilled to be overseeing the market introduction of aXiphen, and work together with my experienced international team as well as with the product experts at aXichem. ", says Christian D. Olesen, who represents the 5[th] generation at the family-owned Chr. Olesen Group.

"We are pleased that aXichem has received the first comments from the European Food Safety Authority (EFSA) on their feed additive application and we are confident that they are approaching an approval from EFSA. aXichem has been working closely with the regulatory team to ensure that all relevant data is submitted to EFSA in the coming months. I'm confident that our experienced team will take lead of a successful launch of aXiphen", says Mads C. Olesen, owner and CEO of Chr. Olesen Group.

"It is great to start working with the pre-launch of aXiphen and to plan the market introduction together with the inspiring and knowledgeable team at Chr. Olesen. I am convinced that aXiphen's value adding qualities will be well-received by the poultry feed producers," says Torsten Helsing, CEO of aXichem.

About phenylcapsaicin and aXiphen
The health benefits of chili, with its active ingredient capsaicin have been known for centuries. aXichem's proprietary molecule, phenylcapsaicin, combines the naturally occurring phenyl group with capsaicin, bridged by a triple bond. The result is an innovative natural analogue capsaicin with high purity, where the pungency is greatly reduced.
Studies have proven the effectiveness of aXiphen[® ]as an ingredient in poultry feed.

A study on on-floor salmonella prevalence, following the inclusion of 15 ppm phenylcapsaicin in a regular starter diet, was carried out in a full-scale commercial broiler production trial under farming conditions. The study comprised 18 broiler farms with 57 broiler chicken houses and 1 659 540 broiler chickens. The study concluded that under the conditions of the study, the inclusion of 15 ppm phenylcapsaicin in broiler chicken feed statistically significantly reduced both the number of farms and the number of houses with salmonella-positive floor boot swabs.

About Chr. Olesen Group

Chr. Olesen is family-owned company established in 1885 in Denmark.

The Company has decades of experience in distributing ingredients to the Feed, Food and Pharma industries all over the world. Chr. Olesen provides product quality and safety, with a knowledge of prices according to market conditions and trends - as well as efficient storage, a global delivery service and timely transportation. The business is built on long term relationships and strategic partnerships with customers and suppliers. More about Chr. Olesen at www.chr-olesen.dk

The information was submitted, through the care of the contact person, for publication on 25 January 2023, at 08:30 AM CEST